Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

BlackRock Technology and Private Equity Term Trust

NYSE BTX
$6.68 -0.03 -0.45%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 11.25 %
Market cap Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.
1.67B
EV Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
1.67B
Beta Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
-
Shares Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
213.34M
YTD Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-15.23 %

Upcoming events BlackRock Technology and Private Equity Term Trust

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart BlackRock Technology and Private Equity Term Trust

Stock analysis BlackRock Technology and Private Equity Term Trust

Indicator Company Industry
P/E (LTM) Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
-43.10 -1.01
P/BV (LTM) Shows the ratio of the market price of the share to the current book value.
0.95 0.94
EV/EBITDA (LTM) Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
-49.28 -0.64
Net Debt/EBITDA (LTM) A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
- 0.74
ROE (LTM) Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
-2.17 -45.42

Price change BlackRock Technology and Private Equity Term Trust per year

5.57$ 8.08$
Min Max

Summary analysis BlackRock Technology and Private Equity Term Trust

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure BlackRock Technology and Private Equity Term Trust

Revenue and net income BlackRock Technology and Private Equity Term Trust

All parameters

About company BlackRock Technology and Private Equity Term Trust

Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York.
Address:
10355 Science Center Drive, San Diego, CA, United States, 92121
Company name: BlackRock Technology and Private Equity Term Trust
Issuer ticker: BTX
ISIN: US1140821000
Country: USA
Exchange: NYSE
Currency: $
IPO date: 1992-03-05
Sector: Healthcare
Industry: Biotechnology
Site: https://www.brooklynitx.com